COVID Vaccines May Boost Cancer Immunotherapy
Cancer patients who received a Moderna or Pfizer/BioNTech messenger RNA (mRNA) COVID-19 vaccine within 100 days of starting immune checkpoint inhibitors were twice as likely as unvaccinated people to live for three years after starting treatment, …